The Use of Artificial Intelligence in Head and Neck Cancers: A Multidisciplinary Survey
Caterina Giannitto,Giorgia Carnicelli,Stefano Lusi,Angela Ammirabile,Elena Casiraghi,Armando De Virgilio,Andrea Alessandro Esposito,Davide Farina,Fabio Ferreli,Ciro Franzese,Gian Marco Frigerio,Antonio Lo Casto,Luca Malvezzi,Luigi Lorini,Ahmed E Othman,Lorenzo Preda,Marta Scorsetti,Paolo Bossi,Giuseppe Mercante,Giuseppe Spriano,Luca Balzarini,Marco Francone
DOI: https://doi.org/10.3390/jpm14040341
2024-03-25
Abstract:Artificial intelligence (AI) approaches have been introduced in various disciplines but remain rather unused in head and neck (H&N) cancers. This survey aimed to infer the current applications of and attitudes toward AI in the multidisciplinary care of H&N cancers. From November 2020 to June 2022, a web-based questionnaire examining the relationship between AI usage and professionals' demographics and attitudes was delivered to different professionals involved in H&N cancers through social media and mailing lists. A total of 139 professionals completed the questionnaire. Only 49.7% of the respondents reported having experience with AI. The most frequent AI users were radiologists (66.2%). Significant predictors of AI use were primary specialty (V = 0.455; p < 0.001), academic qualification and age. AI's potential was seen in the improvement of diagnostic accuracy (72%), surgical planning (64.7%), treatment selection (57.6%), risk assessment (50.4%) and the prediction of complications (45.3%). Among participants, 42.7% had significant concerns over AI use, with the most frequent being the 'loss of control' (27.6%) and 'diagnostic errors' (57.0%). This survey reveals limited engagement with AI in multidisciplinary H&N cancer care, highlighting the need for broader implementation and further studies to explore its acceptance and benefits.